CGTX
$2.93
Cognition Therapeutics
($.03)
(1.01%)
CGTX
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.25)
Revenue:  N/A
Thursday
Aug 3
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CGTX reports earnings?
Beat
Meet
Miss

Where is CGTX's stock price going from here?
Up
Flat
Down
Stock chart of CGTX
Analysts
Summary of analysts' recommendations for CGTX
Score
Grade
Pivots
Resistance
$3.58
$3.34
$3.15

$2.91

Support
$2.72
$2.48
$2.29
Tweet
Growth
Description
Cognition Therapeutics Inc.is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Cognition Therapeutics Inc.is based in PURCHASE, N.Y.